GBA Supports Marketing of Drugs and Registration of Medical Devices from Hong Kong and Macao

The National Medical Products Administration recently unveiled plans to support Hong Kong and Macao-registered operators to produce drugs and medical devices in the Greater Bay Area (GBA). The aim is to promote the integration of the GBA’s biomedicine sector, and to spur collaborative development in the GBA’s medical and pharmaceutical sectors.